Friday, December 28, 2012
Dr. Barakat explains the latest surgical techniques for improving outcomes and quality of life in women with cervical, ovarian, and other gynecologic cancers.
Friday, December 7, 2012
Memorial Sloan Kettering experts add to their knowledge of vemurafenib, a drug recently approved by the FDA to treat some patients with metastatic melanoma.
Monday, December 3, 2012
Memorial Sloan Kettering physicians and nurses take their knowledge and expertise overseas.
Wednesday, November 28, 2012
Gynecologic cancer surgeon Dr. Brown discusses how doctors and nurses collaborate to care for patients, from diagnosis through lifelong follow-up.
Monday, November 12, 2012
Dr. Shah, Chief of the Head and Neck Service, discusses how Memorial Sloan Kettering’s world-renowned head and neck surgeons partner with patients to select the most appropriate treatment plan.
Wednesday, October 31, 2012
Dr. Huang discusses how minimally invasive, video-assisted, and robotic surgical techniques improve the treatment of patients with lung, esophageal, and thyroid cancers.
Thursday, October 25, 2012
Organizers expect this year to be the most successful yet for this national indoor team cycling event, which raises funds for rare cancer research at Memorial Sloan Kettering.
Monday, October 22, 2012
Dr. Abu-Rustum, Director of Minimally Invasive Surgery for the Gynecology Service, discusses how the gynecologic cancer care team treats each woman with an individualized approach.
Friday, October 19, 2012
Dr. DeAngelis has been elected to the Institute of Medicine (IOM), considered one of the highest honors in the field of health and medicine.
Wednesday, October 10, 2012
During Breast Cancer Awareness Month, Dr. Lee discusses mammography, breast MRI, and breast ultrasound.
Wednesday, September 19, 2012
Memorial Sloan Kettering researchers have discovered a way that cancer cells may be able to exchange information by establishing long bridges between cells called tunneling nanotubes.
Thursday, September 13, 2012
Our Annual Report features ten of the year’s most important research and clinical advances, the result of work led by physician-scientists and basic-science investigators.
Monday, September 10, 2012
Memorial Sloan Kettering has announced its intention to build a new, state-of-the-art outpatient cancer treatment facility on Manhattan’s Upper East Side.
Wednesday, September 5, 2012
Internationally recognized physician-scientist José Baselga has been named Physician-in-Chief of Memorial Hospital. He joins Memorial Sloan Kettering from Massachusetts General Hospital.
Friday, August 31, 2012
Enzalutamide, a targeted therapy co-invented by a Memorial Sloan Kettering investigator, has received FDA approval for the treatment of men with metastatic prostate cancer.